High Court Won’t Take Up Daubert Challenge In Depakote Birth Defect Case
WASHINGTON, D.C. — The U.S. Supreme Court on Jan. 7 declined to rule on whether Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), requires additional testing of a Depakote...To view the full article, register now.
Already a subscriber? Click here to view full article